SGYP : Analysis & Opinions

  1. Warning -- The Recent Sell-Off Could Be Just the Beginning

    October 28, 2014
    With oil prices stabilizing, U.S. stock indexes rebounding and volatility on the decline, things are looking a lot better ...
  2. These 3 Stocks May Now Have 100% Upside Potential

    October 27, 2014
    As the market steadily advanced to fresh highs earlier this year, some investors grew queasy. Global tensions, the Fed's ...
  3. 3 Under-The-Radar Stocks With 100% Upside

    October 27, 2014
    As the market steadily advanced to fresh highs earlier this year, some investors grew queasy. Global tensions, the Fed's ...
  4. 4 Health Care Stocks With More Than 100% Upside

    March 13, 2014
    In a bull market that has propped up a wide range of sectors and industries, few have benefited as much as biotech stocks. ...
  5. Why These Risky Biotech Stocks Are Now A Buy...

    November 12, 2013
    As the market continues to flirt with all-time highs, a considerable amount of churn is taking place beneath the surface. ...
  6. Synergy Starts SP-333 Phase I Study - Analyst Blog

    January 29, 2013
    Synergy Pharmaceuticals Inc. (SGYP) recently initiated a phase Ib study on its inflammatory bowel disease (IBD) candidate, ...
  7. Pipeline Progress at Synergy Pharma - Analyst Blog

    December 31, 2012
    Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients suffering ...
Trading Center